Number of the records: 1  

Exploiting the unique features of Zika and Dengue proteases for inhibitor design

  1. 1.
    SYSNO ASEP0517405
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleExploiting the unique features of Zika and Dengue proteases for inhibitor design
    Author(s) Majerová, Taťána (UOCHB-X) RID, ORCID
    Novotný, Pavel (UOCHB-X)
    Krýsová, Eliška (UOCHB-X)
    Konvalinka, Jan (UOCHB-X) RID, ORCID
    Source TitleBiochimie. - : Elsevier - ISSN 0300-9084
    Roč. 166, Nov (2019), s. 132-141
    Number of pages10 s.
    Languageeng - English
    CountryFR - France
    Keywordsactive-site inhibitors ; allosteric inhibitors ; aptamers ; precursor ; Dengue protease ; Zika protease
    Subject RIVCE - Biochemistry
    OECD categoryBiochemistry and molecular biology
    R&D ProjectsLO1302 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Method of publishingLimited access
    Institutional supportUOCHB-X - RVO:61388963
    UT WOS000492314700012
    EID SCOPUS85065797472
    DOI10.1016/j.biochi.2019.05.004
    AnnotationZika and Dengue viruses have attracted substantial attention from researchers in light of recent outbreaks of Dengue fever and increases in cases of congenital microcephaly in areas with Zika incidence. This review summarizes the current state of knowledge about Zika and Dengue proteases. These enzymes have several interesting features: 1) NS3 serine protease requires the activating co-factor NS2B, which is anchored in the membrane of the endoplasmic reticulum, 2) NS2B displays extensive conformational dynamics, 3) NS3 is a multidomain protein with proteolytic, NTPase, RNA 5' triphosphatase and helicase activity and has many protein-protein interaction partners, 4) NS3 is autoproteolytically released from its precursor. Attempts to design tight-binding and specific active-site inhibitors are complicated by the facts that the substrate pocket of the NS2B-NS3 protease is flat and the active-site ligands are charged. The ionic character of potential active-site inhibitors negatively influences their cell permeability. Possibilities to block cis-autoprocessing of the protease precursor have recently been considered. Additionally, potential allosteric sites on NS2B-NS3 proteases have been identified and allosteric compounds have been designed to impair substrate binding and/or block the NS2B-NS3 interaction. Such compounds could be specific to viral proteases, without off-target effects on host serine proteases, and could have favorable pharmacokinetic profiles. This review discusses various groups of inhibitors of these proteases according to their mechanisms of action and chemical structures.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Year of Publishing2020
    Electronic addresshttps://www.sciencedirect.com/science/article/abs/pii/S0300908419301439?via%3Dihub
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.